Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...
As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be ...
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...